Wegovy Weight Loss Medication Treatment

Am I a candidate for Wegovy weight loss medication treatment?

You should meet all of the following criterion for Wegovy:

  1. BMI 30 or more, or 27 or more with a related health problem like high cholesterol or high blood pressure.
  2. Age 12 or over
  3. No personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.
  4. No history of pancreatitis or gastroparesis

In addition, Wegovy® is also indicated to reduce the risk of recurrent heart attack. Read more here.

How much does Wegovy weight loss medication treatment cost?

Semaglutide is sold as Wegovy for weight loss and as Ozempic for the treatment of diabetes. Our staff will work with you and your insurance to get it approved, if you have coverage. If not, please see the FAQ below for more information on cost. We can usually find a cost-effective option even for those without insurance coverage for Wegovy.

Wegovy® Weight Loss
Wegovy vs. Placebo – change in body weight (%) over 2 years.

AI Medication Assistant

Wegovy FAQ

[sp_easyaccordion id=”6202″]

Are you ready to experience the transformative weight loss power of Wegovy?

Say “Goodbye!” to food noise, once and for all!

All treatments, including medications, are provided following a thorough medical evaluation and may not be appropriate for certain individuals. Weight loss amounts listed on this site are taken from published clinical trials involving Wegovy, Zepbound, and Saxenda. Individual results may vary. Please consult with our licensed providers to determine if these options are right for you. The purchase of prescription medications from us is optional. Programs do not include the cost of medication. We stock many medications, but you are welcome to request a written prescription or have our providers e-prescribe to the pharmacy of your choice.

{ “@context”: “https://schema.org”, “@type”: “FAQPage”, “mainEntity”: [ { “@type”: “Question”, “name”: “What is Wegovy and how does it work?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “Wegovy (semaglutide) is a weekly GLP-1 injection that reduces appetite and helps you feel full longer. It is FDA-approved for chronic weight management in adults with obesity or overweight with weight-related health conditions.” } }, { “@type”: “Question”, “name”: “How much weight can I lose with Wegovy?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “In clinical trials, Wegovy produced an average of 15–20% body weight loss over 68 weeks. Individual results vary. Most patients start seeing meaningful weight loss within the first 8–12 weeks of therapy.” } }, { “@type”: “Question”, “name”: “What is the target dose for Wegovy?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “Wegovy’s target maintenance dose is 2.4 mg weekly. Patients start at 0.25 mg and titrate upward every 4 weeks. Reaching the target dose is essential for full therapeutic effect — many patients are underdosed in primary care settings.” } }, { “@type”: “Question”, “name”: “Does insurance cover Wegovy?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “Insurance coverage for Wegovy varies by plan. Many plans cover GLP-1 medications for obesity treatment. Our team at Clinical Nutrition Center verifies your benefits before starting therapy and discusses all cost options upfront.” } }, { “@type”: “Question”, “name”: “What are the side effects of Wegovy?”, “acceptedAnswer”: { “@type”: “Answer”, “text”: “The most common side effects are gastrointestinal — nausea, diarrhea, and constipation — occurring primarily during dose escalation. These are usually manageable and resolve as your body adjusts. Our clinical team monitors every patient closely during titration.” } } ] }

CNC Assistant
Hi! How can I help you today?

Manage Cookies

Necessary
Required for site functions.
Analytics
Allows Google Analytics tracking.